[go: up one dir, main page]

SE8204873D0 - Farmaceutiska preparat, innefattande humant insulin och human c-peptid - Google Patents

Farmaceutiska preparat, innefattande humant insulin och human c-peptid

Info

Publication number
SE8204873D0
SE8204873D0 SE8204873A SE8204873A SE8204873D0 SE 8204873 D0 SE8204873 D0 SE 8204873D0 SE 8204873 A SE8204873 A SE 8204873A SE 8204873 A SE8204873 A SE 8204873A SE 8204873 D0 SE8204873 D0 SE 8204873D0
Authority
SE
Sweden
Prior art keywords
human
peptide
pharmaceutical preparations
human insulin
insulin
Prior art date
Application number
SE8204873A
Other languages
English (en)
Other versions
SE8204873L (sv
SE460334B (sv
Inventor
R E Chance
B H Frank
J A Galloway
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of SE8204873D0 publication Critical patent/SE8204873D0/sv
Publication of SE8204873L publication Critical patent/SE8204873L/sv
Publication of SE460334B publication Critical patent/SE460334B/sv

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/28Insulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
SE8204873A 1981-08-27 1982-08-25 Farmaceutiska preparat, innefattande humant insulin och human c-peptid SE460334B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US29671581A 1981-08-27 1981-08-27

Publications (3)

Publication Number Publication Date
SE8204873D0 true SE8204873D0 (sv) 1982-08-25
SE8204873L SE8204873L (sv) 1983-02-28
SE460334B SE460334B (sv) 1989-10-02

Family

ID=23143238

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8204873A SE460334B (sv) 1981-08-27 1982-08-25 Farmaceutiska preparat, innefattande humant insulin och human c-peptid

Country Status (20)

Country Link
JP (1) JPS5846024A (sv)
AU (1) AU551879B2 (sv)
BE (1) BE894185A (sv)
CA (1) CA1176158A (sv)
CH (1) CH650679A5 (sv)
DE (1) DE3232034A1 (sv)
DZ (1) DZ452A1 (sv)
FR (1) FR2513126B1 (sv)
GB (1) GB2104382B (sv)
IE (1) IE54119B1 (sv)
IL (1) IL66611A0 (sv)
IT (1) IT1153182B (sv)
LU (1) LU84359A1 (sv)
MW (1) MW3882A1 (sv)
NL (1) NL192192C (sv)
NZ (1) NZ201682A (sv)
PH (1) PH19361A (sv)
SE (1) SE460334B (sv)
ZA (1) ZA826159B (sv)
ZW (1) ZW17482A1 (sv)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3326473A1 (de) * 1983-07-22 1985-01-31 Hoechst Ag, 6230 Frankfurt Pharmazeutisches mittel zur behandlung des diabetes mellitus
CA1296253C (en) * 1986-10-20 1992-02-25 Praveen Tyle Stabilized growth hormone compositions
FI882921L (fi) * 1986-10-20 1988-06-17 Novo Industri As Protaminzink-insulinpreparat.
AU612141B2 (en) * 1987-02-25 1991-07-04 Novo Nordisk A/S Novel insulin derivatives
US5212154A (en) * 1987-08-14 1993-05-18 Akzo N.V. Preparation for treating complications in diabetes
DE3863027D1 (de) * 1987-08-14 1991-07-04 Akzo Nv Praeparat zur verhuetung oder bekaempfung von komplikationen bei diabetes.
SE520392C2 (sv) 1996-09-27 2003-07-01 Creative Peptides Sweden Ab C Specifika peptider för behandling av diabetes mellitus
GB0323979D0 (en) 2003-10-13 2003-11-19 Creative Peptides Sweden Ab Therapeutic applications for c-peptide
ES2391776T3 (es) * 2004-11-22 2012-11-29 Novo Nordisk A/S Formulaciones solubles, estables conteniendo insulina con una sal de protamina
GB0511269D0 (en) 2005-06-02 2005-07-13 Creative Peptides Sweden Ab Sustained release preparation of pro-insulin C-peptide
GB0601950D0 (en) * 2006-01-31 2006-03-15 Creative Peptides Sweden Ab Compositions and methods of treating diabetes
MX2011003117A (es) 2008-09-19 2011-04-21 Nektar Therapeutics Conjugados polimericos de peptidos terapeuticos.
US8927488B2 (en) * 2010-05-17 2015-01-06 Cebix, Inc. Pegylated C-peptide
CN104220086A (zh) 2011-11-17 2014-12-17 塞比克斯股份公司 Peg化的c-肽

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2789080A (en) * 1952-08-14 1957-04-16 Christensen Henry Marinus Insulin-albumin compositions
CH330318A (de) * 1953-09-08 1958-05-31 British Drug Houses Ltd Verfahren zur Herstellung eines Insulinpräparates mit verlängerter Wirkungszeit

Also Published As

Publication number Publication date
FR2513126A1 (fr) 1983-03-25
IT8223017A1 (it) 1984-02-27
MW3882A1 (en) 1984-07-11
PH19361A (en) 1986-04-02
LU84359A1 (fr) 1983-02-28
IT8223017A0 (it) 1982-08-27
BE894185A (fr) 1983-02-24
GB2104382A (en) 1983-03-09
NL8203315A (nl) 1983-03-16
SE8204873L (sv) 1983-02-28
FR2513126B1 (fr) 1986-04-18
DE3232034A1 (de) 1983-03-10
DE3232034C2 (sv) 1991-04-11
IE822064L (en) 1983-02-27
IL66611A0 (en) 1982-12-31
CA1176158A (en) 1984-10-16
SE460334B (sv) 1989-10-02
IT1153182B (it) 1987-01-14
CH650679A5 (de) 1985-08-15
ZW17482A1 (en) 1982-11-17
NL192192C (nl) 1997-03-04
ZA826159B (en) 1984-04-25
DZ452A1 (fr) 2004-09-13
GB2104382B (en) 1984-12-19
NZ201682A (en) 1985-08-16
AU551879B2 (en) 1986-05-15
NL192192B (nl) 1996-11-01
IE54119B1 (en) 1989-06-21
AU8759482A (en) 1983-03-03
JPS5846024A (ja) 1983-03-17

Similar Documents

Publication Publication Date Title
IT8720650A0 (it) Derivati dell'etere immidazochinolinilico ad azione farmaceutica e procedimento per laloro preparazione.
IL99699A0 (en) Method of treating or preventing type 1 diabetes by oral administration of insulin
AU4690379A (en) Administering intravenous drugs
DE3668892D1 (en) Hypoglycemische thiazolidinedione.
SE8402560L (sv) Farmaceutisk komposition
ATE198835T1 (de) Knochenwachstumsfördernde zusammensetzung
SE8204873D0 (sv) Farmaceutiska preparat, innefattande humant insulin och human c-peptid
SE8204874L (sv) Farmaceutiska preparat, innefattande humant insulin och humant proinsulin
ES8102141A1 (es) Un procedimiento para preparar compuestos de acido 3-cefem-4-carboxilico disustituido en las posiciones 3 y 7
EP0336368A3 (en) N2-(1-carboxy-3-phenylpropyl)-l-lysine derivative and process of producing lysinopril using the compound
IT8721691A0 (it) Derivati dell'ossima della 1,2,5,6-tetraidropirdin-3-carbossaldeide, loro procedimento di preparazione e loro impiegocome sostanze medicinali.
SE8204872D0 (sv) Farmaceutiska preparat, innefattande humant insulin, human c-peptid och humant proinsulin
NO178286C (no) Fremgangsmåte ved fremstilling av et topisk farmasöytisk preparat inneholdende 1
FI890779L (sv) 14,17 -etano-14 -estratriener, förfarande för deras framställning och preparat innehållande dem för att användas som preventiomedel
DK0450123T3 (da) Farmaceutisk præparat til topisk administration indeholdende dichlofenac-natrium
IT7823016A0 (it) Composto farmaceutico di migliorata attivita' mucolitica e fluidificante delle secrezioni mucose.
SE8204871L (sv) Farmaceutiska preparat, innefattande humant proinsulin
SE8704240D0 (sv) Analgesic preparations
IT7824578A0 (it) Composizione farmaceutica per la terapia di stati di frigidita' ed impotenza.
PT85454A (de) Verwendung von 15-deoxyspergualin als arzneimittel
NL7903434A (nl) Derivaten van benzoylfenoxyalkaancarbonzuren met anti- lipemische en anticholesterolemische werking, alsmede farmaceutische preparaten die zo'n verbinding bevatten.
FI834429A7 (sv) Framställning och terapeutisk tillämpning av 3',5'-diarabinosider.
SE8705035L (sv) Anvaendning av alkylglycerol
NZ193079A (en) Derivatives of 1, 1'-biphenyl-2-yl-alkylamine medicinal preparations
KR900700484A (ko) 1,4:3,6-디안히드로 헥시톨 잘산염의 아미노프로판올 유도체,그의 제법 및 약제로서의 그의 용도

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8204873-7

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8204873-7

Format of ref document f/p: F